Compare Larazotide (evidence B) and TB-500 (evidence D) on mechanism, clinical status, safety, and dosing.
Larazotide (AT-1001) is a synthetic 8-amino acid peptide that acts as a tight junction regulator. It is being developed as an oral adjunct therapy for celiac…
TB-500 is a synthetic fragment of thymosin beta-4 (Tβ4), a naturally occurring 43-amino-acid peptide found throughout human tissues. TB-500 contains the…
Full profiles: Larazotide, TB-500.